The planned logistics site, near a principal manufacturing facility, will handle global distribution of Boston Scientific’s ...
In late April 2026, Boston Scientific reported quarterly revenue of US$5.20 billion, up 11.6% year on year and ahead of ...
Zacks Investment Research on MSN
Brokers suggest investing in Boston Scientific (BSX): Read this before placing a bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
Valued at a market cap of $71.8 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets minimally ...
The ASR serves as a key component of Boston Scientific Corporation’s (NYSE:BSX) capital allocation strategy. By using its ...
Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today ...
Boston Scientific Corporation chooses central Indiana for a $138 million medical device distribution facility, creating up to ...
Indiana Gov. Mike Braun announced that Boston Scientific plans to open a new global medical device distribution facility in ...
Boston Scientific (NYSE:BSX) is preparing to release its quarterly earnings on Wednesday, 2025-04-23. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...
CHONGQING, CHINA - APRIL 20: In this photo illustration, the logo of Boston Scientific Corporation is displayed on a smartphone screen, with the company's branding and slogan Advancing science for ...
Boston Scientific (BSX) stock hits a 52-week low as the company highlights a slowdown in demand for its WATCHMAN cardiac ...
Boston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021, and it now seems to be fully valued. Boston Scientific BSX saw its stock trading at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results